< sup > 177 < /sup > Lu-PSMA-617 Radioligand Treatment in Elderly Patients with Metastatic Castration-resistant Prostate Cancer: Therapeutic Efficacy and Safety Assessment

CONCLUSION: 177Lu-PSMA-617 treatment was a safe and effective treatment option for properly selected elderly mCRPC patients.PMID:38571351 | DOI:10.2174/0118744710284661240328094119

Source: Current Radiopharmaceuticals - April 4, 2024 Category: Radiology Authors: Ertan Sahin Umut Elboga Ufuk Cimen Merve Okuyan Yusuf Burak Cayirli Source Type: research